Skip to content

Effect of Citrate-Containing Foods on Blood Alcohol Concentration - A Randomized Controlled Trial -

Effect of Citrate-Containing Foods on Blood Alcohol Concentration. - Effect of Citrate-Containing Foods on Blood Alcohol Concentration.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043146
Enrollment
13
Registered
2021-01-31
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Pre-inoculate with citrate-containing foods 30 minutes before taking alcohol. Pre-inoculation with placebo food 30 minutes before taking alcohol.

Sponsors

LLC.okutoeru Nihon Pharmaceutical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese adult males and females 2) Age 20 years or older at the time of consent intake 3) Those with drinking habits 4) Those who have understood the purpose and content of the study and have given their consent. 5) Those who have been judged to have no problem participating in the study

Exclusion criteria

Exclusion criteria: 1) Persons who are intolerant to alcohol 2) Those who are regularly using medicines, food for specified health uses, functional foods, health foods, etc. that may affect the study. 3) Those who are currently participating in other human trials as study subjects, or within 4 weeks of the end of the trial in which they participated. 4) Those with positive test results for hepatitis B, hepatitis C, HIV, or human T-cell leukemia virus. 5) Those who have a history of drug allergy or food allergy. 6) Those who fall under any of the following categories Those with heart, liver, or kidney disease (including complications from other diseases) 7) Those who have other problems with participation. 8) Those who are pregnant, lactating, or plan to become pregnant during the study period.

Design outcomes

Primary

MeasureTime frame
Evaluation of efficacy: blood alcohol concentration , area under the blood concentration time curve (AUC)

Secondary

MeasureTime frame
Evaluation of safety: adverse events

Countries

Japan

Contacts

Public ContactYoshihiro Iwahori

LLC.okutoeru headquarters

info@okutoeru.com03-6864-7123

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026